Target intelligence / Profile preview

Onchocerca volvulus retinol-binding protein-like 2 (Ov-RAL-2) (Ov-RAL-2)

Target
Ov-RAL-2
Molecular classification
Antigen, Lipid-binding protein, Other
01

Overview

Onchocerca volvulus retinol-binding protein-like 2 (Ov-RAL-2) is a protein from the parasitic nematode Onchocerca volvulus, the causative agent of onchocerciasis, also known as river blindness (UniProt: P36990). It belongs to the RAL-2 family of proteins, which are structurally related to retinol-binding proteins and are thought to play a role in lipid transport or sequestration necessary for parasite development (PubMed: 8137014). Ov-RAL-2 is highly immunogenic and is expressed primarily in the infective third-stage larvae (L3), where it is localized to the hypodermis and cuticle (PubMed: 26053138). It is a primary candidate for the development of a prophylactic vaccine against onchocerciasis; experimental studies have shown that a fusion or co-administration of Ov-RAL-2 with the antigen Ov-103 can significantly reduce parasite burden in animal models (PubMed: 25514367, PubMed: 30114073). Additionally, the protein is used as a diagnostic marker in serological tests to detect exposure to the parasite and monitor the success of elimination programs (PubMed: 28355213).

Other names
RAL-2Retinol-binding protein-like 2Ov-RAL2Onchocerca volvulus antigen RAL-2
02

Mechanism of action

Induction of protective humoral and cellular immune responses against infective larvae (L3) of Onchocerca volvulus.

03

Biological functions

Immune responseRetinol bindingLipid transportOther
04

Disease associations

Infection
05

Safety considerations

Potential for allergic reactions due to its nature as an allergenCross-reactivity with other nematode proteins
06

Interacting drugs

Ov-103/Ov-RAL-2 vaccine (experimental)
07

Biomarkers

Anti-Ov-RAL-2 IgG antibodiesAnti-Ov-RAL-2 IgE antibodies

Beyond the preview

Go deeper on Onchocerca volvulus retinol-binding protein-like 2 (Ov-RAL-2) (Ov-RAL-2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Onchocerca volvulus retinol-binding protein-like 2 (Ov-RAL-2) (Ov-RAL-2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call